{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:24:00Z","timestamp":1776378240415,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL125735-01"],"award-info":[{"award-number":["R01HL125735-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL128563-04"],"award-info":[{"award-number":["R01HL128563-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR001417"],"award-info":[{"award-number":["UL1TR001417"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL147549-01"],"award-info":[{"award-number":["R01HL147549-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32HL129948-01"],"award-info":[{"award-number":["T32HL129948-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008333","name":"University of Alabama at Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008333","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.amjcard.2020.04.038","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T18:47:01Z","timestamp":1589568421000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Cardiac Function and Sudden Cardiac Death in Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)"],"prefix":"10.1016","volume":"129","author":[{"given":"Rajat","family":"Kalra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartik","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Sheets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeep","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indranee","family":"Rajapreyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Cribbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar Julian","family":"Booker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumanth D.","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navkaranbir S.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2020.04.038_bib0001","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics\u20142019 update","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0002","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jacc.2016.10.078","article-title":"Mode of death in heart failure with preserved ejection fraction","volume":"69","author":"Vaduganathan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0003","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10741-016-9525-z","article-title":"Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?","volume":"21","author":"Vaduganathan","year":"2016","journal-title":"Heart failure reviews"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0004","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.0000144474.65922.AA","article-title":"Effect of candesartan on cause-specific mortality in heart failure patients: the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program","volume":"110","author":"Solomon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0005","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.109.909614","article-title":"Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in heart failure with preserved ejection fraction study (I-Preserve) trial","volume":"121","author":"Zile","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0006","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ejhf.172","article-title":"A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction","volume":"16","author":"Adabag","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0007","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.114.001583","article-title":"Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0008","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/CIRCULATIONAHA.115.015884","article-title":"Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone","volume":"132","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0009","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ahj.2011.09.007","article-title":"Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction","volume":"162","author":"Desai","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0010","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"New Engl J Med"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0011","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.amjcard.2020.01.046","article-title":"Anemia, ortality, and hospitalizations in heart failure with a preserved ejection fraction (from the TOPCAT Trial)","volume":"125","author":"Gupta","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0012","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0013","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJMc1612601","article-title":"Spironolactone metabolites in TOPCAT - new nsights into regional variation","volume":"376","author":"de Denus","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiography"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jacc.2013.09.052","article-title":"Impaired systolic function by strain imaging in heart failure with preserved ejection fraction","volume":"63","author":"Kraigher-Krainer","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0016","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1054-8807(01)00091-6","article-title":"Sudden cardiac death","volume":"10","author":"Virmani","year":"2001","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0017","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIRCULATIONAHA.117.028202","article-title":"Delayed repolarization underlies ventricular arrhythmias in rats with heart failure and preserved ejection fraction","volume":"136","author":"Cho","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00145","article-title":"QRS-T angle predicts cardiac risk and correlates with global longitudinal strain in prevalent hemodialysis patients","volume":"10","author":"Skampardoni","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0019","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jamacardio.2017.2511","article-title":"Temporal relation between myocardial fibrosis and heart failure with preserved ejection fraction: association with baseline disease severity and subsequent outcome","volume":"2","author":"Schelbert","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joa.2013.12.008","article-title":"Cardiac fibrosis as a determinant of ventricular tachyarrhythmias","volume":"30","author":"Morita","year":"2014","journal-title":"J Arrhythmia"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0021","first-page":"991","article-title":"CMR-Verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF","volume":"7","author":"Su","year":"2014","journal-title":"JACC: Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0022","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10554-016-0881-5","article-title":"Fibrosis assessment by integrated backscatter and its relationship with longitudinal deformation and diastolic function in heart failure with preserved ejection fraction","volume":"32","author":"Carluccio","year":"2016","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0023","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/echo.12613","article-title":"Speckle strain echocardiography predicts outcome in patients with heart failure with both depressed and preserved left ventricular ejection fraction","volume":"32","author":"Stampehl","year":"2015","journal-title":"Echocardiography (Mount Kisco, NY)"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10554-013-0310-y","article-title":"Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?","volume":"30","author":"Pellicori","year":"2014","journal-title":"Int J Cardiovascu Imaging"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0025","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.jcmg.2018.11.031","article-title":"Relationship etween focal and diffuse fibrosis assessed by CMR and clinical outcomes in heart failure with preserved ejection fraction","volume":"12","author":"Kanagala","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0026","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cardfail.2012.08.357","article-title":"Sudden cardiac death in heart failure patients with preserved ejection fraction","volume":"18","author":"Adabag","year":"2012","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0027","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an mplantable cardioverter\u2013defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0028","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a efibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.amjcard.2020.04.038_bib0029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"New Engl J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920304586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920304586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:05:13Z","timestamp":1762077913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914920304586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":29,"alternative-id":["S0002914920304586"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.04.038","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Function and Sudden Cardiac Death in Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}